Eric Francois
CIK: 0001656125
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Francois Eric
Francois Eric (SEC CIK 0001656125) files insider reports with the SEC as Director of 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and Director of CERO THERAPEUTICS HOLDINGS, INC. (CERO).
Signal8 holds 3 ownership filings by Francois Eric (2 Form 3, 1 Form 4), filed between Apr 21, 2026 and May 19, 2026. Those filings report 1 transaction, the latest on Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Francois Eric's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Francois Eric
- Mar 4, 2026: Grant or award of CERO derivative securities (Form 4, code A).
Other insiders filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Knight Therapeutics Inc., 10% Owner
- DOW GEOFFREY S, President and CEO
- Landon Kristen, Chief Operating Officer
- XU CHERYL, Director
- MILLER TYRONE, CFO